What does Dr. Thomas Billiet do?

Dr. Thomas Billiet is a specialist medical practice in Brugge. Private Limited, started on 7 January 2021, 1 establishment.

What is the address of Dr. Thomas Billiet?

The registered office of Dr. Thomas Billiet is located at Abelendreef 12, 8200 Brugge.

Is Dr. Thomas Billiet still active?

Yes. According to the CBE (31 October 2026) Dr. Thomas Billiet is active, legal situation “Normale toestand”, started on 7 January 2021.

Is Dr. Thomas Billiet registered on Peppol?

Yes, Dr. Thomas Billiet is registered on the Peppol network with ID 0208:0760958961.

What is the enterprise number of Dr. Thomas Billiet?

The enterprise number of Dr. Thomas Billiet is BE0760958961.

When was Dr. Thomas Billiet founded?

Dr. Thomas Billiet was founded on 7 January 2021.

Who are the directors of Dr. Thomas Billiet?

According to the 2025 annual accounts, the directors of Dr. Thomas Billiet are: Thomas Billiet.

Is Dr. Thomas Billiet a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 January 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Thomas Billiet make in 2025?

Dr. Thomas Billiet posted a profit after taxes of € 427,128 in financial year 2025.

What is the revenue of Dr. Thomas Billiet?

As a small company, Dr. Thomas Billiet is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 580,526.

Dr. Thomas Billiet (Private Limited) - Brugge

Dossier Dr. Thomas Billiet, printed on 31 October 2026 from databakkes.be/en/0760958961/dr-thomas-billiet. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Thomas Billiet from Brugge, company number BE0760958961, closed financial year 2025 with a result of € 427,128 after tax. For that financial year Dr. Thomas Billiet recorded a gross margin of € 580,526 and equity of € 44,139. Compared with financial year 2024, the result moved from € 195,302 to € 427,128. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.

What it is worth Growing

€ 44,139

▲ € 42,128 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 427,128

▲ 119% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 108,904

▼ 9% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 385,000 paid out

90 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 6,769

▼ 6% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 5,250

▼ 93% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 200,256 Gross margin 2022: € 200,256 First fiscal year in the series	€ 262,018 Gross margin 2023: € 262,018 ▲ 31% vs 2022 (€ 200,256) Favourable step	€ 273,217 Gross margin 2024: € 273,217 ▲ 4% vs 2023 (€ 262,018) Favourable step	€ 580,526 Gross margin 2025: € 580,526 ▲ 112% vs 2024 (€ 273,217) Favourable step	▲ 112%
Profit after taxes	€ 143,541 Profit after taxes 2022: € 143,541 First fiscal year in the series	€ 188,613 Profit after taxes 2023: € 188,613 ▲ 31% vs 2022 (€ 143,541) Favourable step	€ 195,302 Profit after taxes 2024: € 195,302 ▲ 4% vs 2023 (€ 188,613) Favourable step	€ 427,128 Profit after taxes 2025: € 427,128 ▲ 119% vs 2024 (€ 195,302) Favourable step	▲ 119%
Equity	€ 237,096 Equity 2022: € 237,096 First fiscal year in the series	€ 425,709 Equity 2023: € 425,709 ▲ 80% vs 2022 (€ 237,096) Favourable step	€ 2,011 Equity 2024: € 2,011 ▼ € 423,698 vs 2023 (€ 425,709) Unfavourable step	€ 44,139 Equity 2025: € 44,139 ▲ € 42,128 vs 2024 (€ 2,011) Favourable step	▲ € 42,128
Total debts	€ 66,702 Total debts 2022: € 66,702 First fiscal year in the series	€ 85,600 Total debts 2023: € 85,600 ▲ 28% vs 2022 (€ 66,702) Unfavourable step	€ 288,964 Total debts 2024: € 288,964 ▲ 238% vs 2023 (€ 85,600) Unfavourable step	€ 136,491 Total debts 2025: € 136,491 ▼ 53% vs 2024 (€ 288,964) Favourable step	▼ 53%
Cash	€ 207,678 Cash 2022: € 207,678 First fiscal year in the series	€ 84,088 Cash 2023: € 84,088 ▼ 60% vs 2022 (€ 207,678) Unfavourable step	€ 119,316 Cash 2024: € 119,316 ▲ 42% vs 2023 (€ 84,088) Favourable step	€ 108,904 Cash 2025: € 108,904 ▼ 9% vs 2024 (€ 119,316) Unfavourable step	▼ 9%
Land & buildings	€ 16,464 Land & buildings 2022: € 16,464 First fiscal year in the series	€ 14,587 Land & buildings 2023: € 14,587 ▼ 11% vs 2022 (€ 16,464) Unchanged	€ 18,202 Land & buildings 2024: € 18,202 ▲ 25% vs 2023 (€ 14,587) Unchanged	€ 14,997 Land & buildings 2025: € 14,997 ▼ 18% vs 2024 (€ 18,202) Unchanged	▼ 18%
Retained profit	€ 235,596 Retained profit 2022: € 235,596 First fiscal year in the series	€ 424,209 Retained profit 2023: € 424,209 ▲ 80% vs 2022 (€ 235,596) Favourable step	€ 511 Retained profit 2024: € 511 ▼ € 423,698 vs 2023 (€ 424,209) Unfavourable step	€ 42,639 Retained profit 2025: € 42,639 ▲ € 42,128 vs 2024 (€ 511) Favourable step	▲ € 42,128
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 619,000 Dividend 2024: € 619,000 Unchanged (€ 0) Unchanged	€ 385,000 Dividend 2025: € 385,000 ▼ 38% vs 2024 (€ 619,000) Unchanged	▼ 38%
Balance sheet total	€ 303,798 Balance sheet total 2022: € 303,798 First fiscal year in the series	€ 511,308 Balance sheet total 2023: € 511,308 ▲ 68% vs 2022 (€ 303,798) Unchanged	€ 290,975 Balance sheet total 2024: € 290,975 ▼ 43% vs 2023 (€ 511,308) Unchanged	€ 180,630 Balance sheet total 2025: € 180,630 ▼ 38% vs 2024 (€ 290,975) Unchanged	▼ 38%

Key figures of Dr. Thomas Billiet, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Thomas Billiet?

What happened at Dr. Thomas Billiet in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 22, 2026 New annual accounts for financial year 2025: profit of € 427,128 (▲ 119% vs 2024). Source: NBB ↗
Jan 7, 2021 New establishment in Brugge. KBO
Jan 7, 2021 Start of the company according to the CBE. KBO

In short

From € 143,541 profit in 2022 to € 427,128 profit in 2025.

Paid € 312,959 in corporate taxes since 2022.

Best year ever: 2025, with € 427,128 profit.

Paid out € 1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Thomas Billiet

Dr. Thomas Billiet

Behind Dr. Thomas Billiet is Thomas Billiet.

Directors

According to the 2025 annual accounts

Thomas Billiet

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Abelendreef 12

8200 Brugge

2.311.628.081

De Klokke-Zuid 31

8200 Brugge

Active since 7 January 2021

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Dr. Barbara Veys

€ 718,605 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0760.958.961
VAT number: BE 0760.958.961
Registered office: Abelendreef 12, 8200 Brugge
Names & denominations: Dr. Thomas Billiet
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 January 2021
Peppol: Active · Active since 15 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗